These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31522676)

  • 1. Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study.
    El-Houseini ME; Ismail A; Abdelaal AA; El-Habashy AH; Abdallah ZF; Mohamed MZ; El-Hadidi M; Cho WCS; Ahmed H; Al-Shafie TA
    Biochemistry (Mosc); 2019 Aug; 84(8):941-953. PubMed ID: 31522676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
    El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
    MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
    BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection.
    Kim HG; Chung YH; Song BC; Kim J; Yang SH; Lee YS; Suh DJ
    Korean J Intern Med; 2000 Dec; 15(3):165-70. PubMed ID: 11242803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.
    El Bassuoni MA; Talaat RM; Ibrahim AA; Shaker OT
    Egypt J Immunol; 2008; 15(1):39-50. PubMed ID: 20306668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 polymorphism 509 C>T is associated with an increased risk for hepatocellular carcinoma in HCV-infected patients.
    Ma J; Liu YC; Fang Y; Cao Y; Liu ZL
    Genet Mol Res; 2015 May; 14(2):4461-8. PubMed ID: 25966218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between transforming growth factor-β1 -509 C>T variants and hepatocellular carcinoma susceptibility: a meta-analysis.
    Toshikuni N; Matsue Y; Minato T; Hayashi N; Tsutsumi M
    Neoplasma; 2016; 63(6):961-966. PubMed ID: 27596296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90.
    Yoshida M; Yamashita T; Okada H; Oishi N; Nio K; Hayashi T; Nomura Y; Hayashi T; Asahina Y; Ohwada M; Sunagozaka H; Takatori H; Colombo F; Porretti L; Honda M; Kaneko S
    Sci Rep; 2017 Sep; 7(1):11292. PubMed ID: 28900199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.
    Rojas A; Zhang P; Wang Y; Foo WC; Muñoz NM; Xiao L; Wang J; Gores GJ; Hung MC; Blechacz B
    Neoplasia; 2016 Jun; 18(6):371-86. PubMed ID: 27292026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
    Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
    BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p.
    Dong KS; Chen Y; Yang G; Liao ZB; Zhang HW; Liang HF; Chen XP; Dong HH
    Oncogene; 2020 Feb; 39(8):1807-1820. PubMed ID: 31740785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.
    Ali MA; Koura BA; el-Mashad N; Zaghloul MH
    Egypt J Immunol; 2004; 11(1):83-90. PubMed ID: 15724390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long non-coding RNA MEG3 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by upregulating TGF-β1.
    Dong H; Zhang Y; Xu Y; Ma R; Liu L; Luo C; Jiang W
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):645-652. PubMed ID: 31089680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 upregulates the expression of lncRNA UCA1 and its downstream HXK2 to promote the growth of hepatocellular carcinoma.
    Hu ML; Wang XY; Chen WM
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4846-4854. PubMed ID: 30070319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression.
    Rani B; Malfettone A; Dituri F; Soukupova J; Lupo L; Mancarella S; Fabregat I; Giannelli G
    Cell Death Dis; 2018 Mar; 9(3):373. PubMed ID: 29515105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.